Micromedex NeoFax conveys evidence-based neonatal drug and nutrition information
advertisement
| 名前 | Micromedex NeoFax Reference |
|---|---|
| バージョン | 4.6.0 |
| アップデート | 2024年07月31日 |
| サイズ | 16 MB |
| カテゴリー | 医療 |
| インストール | 10千+ |
| 開発元 | Merative |
| Android OS | Android 5.0+ |
| Google Play ID | com.merative.neofax |
Micromedex NeoFax Reference · スクリーンショット
Micromedex NeoFax Reference · 説明
Micromedex NeoFax Reference is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Merative Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex® for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to Merative Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the Micromedex NeoFax password contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
Merative Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex® for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to Merative Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the Micromedex NeoFax password contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
